New Horizons in Personalized Care for Metastatic Bladder Cancer consists of a single lecture, New Horizons in Personalized Care for Metastatic Bladder Cancer with discussion by Matthew I. Milowsky, MD and Matthew Galsky, MD.

After viewing New Horizons in Personalized Care for Metastatic Bladder Cancer, you will be better able to:
• Evaluate the role of new targeted and immune-based agents in the first- and second-line metastatic settings, and how they can be integrated into practice
• Apply strategies and tools that enhance patient-clinician communication and shared decision making processes

Target Audiences:
This program is intended for Medical/genitourinary oncologists, urologists, surgeons, radiologists, and other health care professionals (primary care physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with bladder cancer.

ScientiaCME Immunology contains a single lecture:
Therapeutic Updates, Best Practices, and Barriers to Care in the Treatment and Prevention of Kidney Transplant Rejection.

Target Audience:
Physicians specializing in Immunology, Nephrology, Urology